Skip to content
Stocks News
Enter Ticker Symbol
  • Home
  • FEATURED COMPANY
  • ANALYST COVERAGE
  • NEWS
  • SUBSCRIBE
  • CONTACT

ANALYST COVERAGE

this-harrow-analyst-begins-coverage-on-a-bullish-note;-here-are-top-5-initiations-for-friday-–-harrow-(nasdaq:hrow),-janux-therapeutics-(nasdaq:janx)

This Harrow Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday – Harrow (NASDAQ:HROW), Janux Therapeutics (NASDAQ:JANX)

Jul 11, 2025

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst…

Read more
cantor-fitzgerald-initiates-coverage-on-tvardi-therapeutics-stock-with-overweight-rating-by-investing.com

Cantor Fitzgerald initiates coverage on Tvardi Therapeutics stock with Overweight rating By Investing.com

Jul 11, 2025

Cantor Fitzgerald initiates coverage on Tvardi Therapeutics stock with Overweight rating

Read more
jpmorgan-maintains-neutral-rating-on-medtronic-stock-amid-renal-denervation-coverage-win-by-investing.com

JPMorgan maintains Neutral rating on Medtronic stock amid renal denervation coverage win By Investing.com

Jul 11, 2025

JPMorgan maintains Neutral rating on Medtronic stock amid renal denervation coverage win

Read more
medtronic-stock-rises-as-cms-proposes-favorable-coverage-for-rdn-therapy-by-investing.com

Medtronic stock rises as CMS proposes favorable coverage for RDN therapy By Investing.com

Jul 11, 2025

Medtronic stock rises as CMS proposes favorable coverage for RDN therapy

Read more
jpmorgan-maintains-neutral-rating-on-medtronic-stock-amid-renal-denervation-coverage-win-by-investing.com

JPMorgan maintains Neutral rating on Medtronic stock amid renal denervation coverage win By Investing.com

Jul 11, 2025

JPMorgan maintains Neutral rating on Medtronic stock amid renal denervation coverage win

Read more
medtronic-stock-poised-to-rise-as-cms-proposes-broader-renal-denervation-coverage-by-investing.com

Medtronic stock poised to rise as CMS proposes broader renal denervation coverage By Investing.com

Jul 11, 2025

Medtronic stock poised to rise as CMS proposes broader renal denervation coverage

Read more
analyst-initiates-coverage-on-karyopharm-(kpti)-with-positive-outlook

Analyst Initiates Coverage on Karyopharm (KPTI) with Positive Outlook

Jul 11, 2025

An analyst from H.C. Wainwright, Robert Burns, has started coverage of Karyopharm Therapeutics (KPTI, Financial) with a Buy…

Read more
canadian-analyst-coverage-update:-july-10th

Canadian Analyst Coverage Update: July 10th

Jul 11, 2025

Analyst Ratings (Canada) Adentra (ADEN:CA) had its target price updated by Stifel Nicolaus to $44.00 with a Buy…

Read more
sage-group-shares-(lon:-sge)-gain-bullish-new-analyst-coverage

Sage Group Shares (LON: SGE) Gain Bullish New Analyst Coverage

Jul 11, 2025

Sage Group shares (LON: SGE) have been given a boost, with a new initiation of coverage seeing the…

Read more
analyst-ratings-coverage-update:-july-10th,-2025

Analyst Ratings Coverage Update: July 10th, 2025

Jul 11, 2025

Analyst Ratings (USA) American Airlines Group (AAL) had its target price raised to $12.00 by Barclays, maintaining an…

Read more
latest-analyst-coverage:-july-9th,-2025

Latest Analyst Coverage: July 9th, 2025

Jul 11, 2025

Analyst Ratings (USA) 3M (MMM) had its target raised by Barclays from $164.00 to $170.00, maintaining an Overweight…

Read more
analyst-ratings-coverage-update:-july-10th,-2025

Analyst Ratings Coverage Update: July 10th, 2025

Jul 11, 2025

Analyst Ratings (USA) American Airlines Group (AAL) had its target price raised to $12.00 by Barclays, maintaining an…

Read more
  1. Pages:
  2. «
  3. 1
  4. ...
  5. 183
  6. 184
  7. 185
  8. 186
  9. 187
  10. 188
  11. 189
  12. ...
  13. 384
  14. »

Posts pagination

Newer posts Page 1 … Page 186 … Page 384 Older posts

The content presented on this site is intended solely for entertainment purposes and should not be construed as an invitation to engage in the purchase or sale of securities. Each content provider featured on 10x Wealth Report brings a unique perspective and predisposition, which may not necessarily align with that of 10x Wealth Report. It is crucial to recognize that 10x Wealth Report is not a registered financial advisor or firm. Read More full disclaimer

CATEGORIES

  • FEATURED COMPANY
  • NEWS
  • ANALYST COVERAGE
  • Special Post
  • CONTACT
  • SUBSCRIBE
  • Privacy Policy
  • Terms or Service
  • Disclaimer

CONNECT & FOLLOW

© 10x Wealth Report Copyright 2024.